ios 11212 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumane, L; Boucher, JL; Isajevs, S; Leonova, E; Rostoka, E; Sjakste, N; Sjakste, T; Sokolovska, J | 1 |
| Briede, J; Daija, D; Duburs, G; Stivrina, M | 1 |
2 other study(ies) available for ios 11212 and Alloxan Diabetes
| Article | Year |
|---|---|
New 1,4-Dihydropyridines Down-regulate Nitric Oxide in Animals with Streptozotocin-induced Diabetes Mellitus and Protect Deoxyribonucleic Acid against Peroxynitrite Action.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dihydropyridines; DNA; Down-Regulation; Kidney; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Protective Agents; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Xanthine Dehydrogenase | 2016 |
Effect of cerebrocrast on the lymphocyte blast transformation activity in normal and streptozotocin-induced diabetic rats.
Topics: Animals; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Dihydropyridines; Interleukin-2; Lymphocyte Activation; Rats; Rats, Inbred Strains; Reference Values | 1999 |